S&P Futures
3,812.25 -15.00 (-0.39%) Dow Futures
30,948.00 -113.00 (-0.36%) Nasdaq Futures
11,560.25 -51.00 (-0.44%) Russell 2000 Futures
1,719.30 -9.20 (-0.53%) Crude Oil
110.30 +1.87 (+1.72%) Gold
1,807.40 +5.90 (+0.33%)
GelStat Corporation (GSAC)
Chart Events
Performance Outlook
| Previous Close | 0.0024 |
| Open | 0.0025 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0024 - 0.0024 |
| 52 Week Range | 0.0010 - 0.0469 |
| Volume | |
| Avg. Volume | 76,717 |
| Market Cap | 1.246M |
| Beta (5Y Monthly) | 0.85 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0010 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
GelStat Provides Corporate Update on Capital Restructuring
STUART, Fla., March 08, 2022 (GLOBE NEWSWIRE) -- GelStat Corporation ("GelStat" or the "Company") (OTCPink: GSAC), a development stage company focused on the marketing of over-the-counter and other non-prescription, natural consumer health care products, today provided several updates related to its ongoing capital markets activities and corporate initiatives. As previously announced, the Company is in the process of conducting a Regulation A+, Tier 2, equity financing of up to $5 million (the “
- GlobeNewswire
GelStat Announces $5 Million Public Offering Under Regulation A+
GelStat Corporation Has Been Qualified by the SEC for a Regulation A+ Public OfferingSTUART, Fla., Feb. 08, 2022 (GLOBE NEWSWIRE) -- GelStat Corporation ("GelStat" or the "Company") (OTCPink: GSAC), a development stage company focused on the marketing of over-the-counter and other non-prescription, natural consumer health care products, announced the launch of a Regulation A+, Tier 2, equity financing of up to $5 million (the “Public Offering”). A copy of the Company's offering circular for the
